It could ameliorate the hypertrophic H9c2 cells by decreasing the HIF-1α and PPARγ pathways, and it can inhibit calcium movements through cell membranes to treat cardiovascular disease (Sun et al., 2013; Niu et al., 2021). The gene discussed is HIF1A; the disease is cardiovascular disorder.